News
X4 Pharma gets first FDA okay for WHIM syndrome drug
Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA.
Wednesday 27 November 2024
